Lassmann M - Search Results

1

[Radiation exposure in (90)Y-Zevalin therapy: results of a prospective multicentre trial].

Geworski L, Zöphel K, Rimpler A, Barth I, Lassmann M, Sandrock D, Zander A, Halm T, Hänscheid H, Hofmann M, Reiners C, Munz DL. Geworski L, et al. Among authors: lassmann m. Nuklearmedizin. 2006;45(2):82-6; quiz N15-6. Nuklearmedizin. 2006. PMID: 16547569 German.

2

[Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases].

Lassmann M, Hänscheid H, Schelper LF, Körber C, Reiners C. Lassmann M, et al. Nuklearmedizin. 1998 May;37(3):120-3. Nuklearmedizin. 1998. PMID: 9604233 German.

3

[Aa DICOM based PACS for nuclear medicine].

Lassmann M, Reiners C. Lassmann M, et al. Nuklearmedizin. 2002 Feb;41(1):52-60. Nuklearmedizin. 2002. PMID: 11917350 German.

4

[Monitoring of 131I incorporation in nuclear medicine personnel by self accomplished measurements].

Hänscheid H, Lassmann M, Aulbach F, Reiners C. Hänscheid H, et al. Among authors: lassmann m. Nuklearmedizin. 2003 Feb;42(1):45-9. Nuklearmedizin. 2003. PMID: 12601454 German.

5

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

Lassmann M, Luster M, Hänscheid H, Reiners C. Lassmann M, et al. J Nucl Med. 2004 Apr;45(4):619-25. J Nucl Med. 2004. PMID: 15073258 Free article. Clinical Trial.

6

(131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies.

Verburg FA, Luster M, Lassmann M, Reiners C. Verburg FA, et al. Among authors: lassmann m. Nuklearmedizin. 2011;50(3):93-9; quiz N20. doi: 10.3413/Nukmed-0341-10-08. Epub 2010 Dec 17. Nuklearmedizin. 2011. PMID: 21165539

7

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, Ladenson PW, Wahl RL, Schlumberger M, Ricard M, Driedger A, Kloos RT, Sherman SI, Haugen BR, Carriere V, Corone C, Reiners C. Hänscheid H, et al. Among authors: lassmann m. J Nucl Med. 2006 Apr;47(4):648-54. J Nucl Med. 2006. PMID: 16595499 Free article. Clinical Trial.

8

A perspective on post-Chernobyl radioablation in young females.

Reiners C, Lassmann M, Hänscheid H. Reiners C, et al. Among authors: lassmann m. J Nucl Med. 2006 Oct;47(10):1563-4. J Nucl Med. 2006. PMID: 17015887 Free article. No abstract available.

9

Spatial dose mapping for individualizing radioiodine treatment.

Lassmann M, Hänscheid H. Lassmann M, et al. J Nucl Med. 2007 Jan;48(1):2-4. J Nucl Med. 2007. PMID: 17204691 Free article. No abstract available.

10

Dosimetry prior to I-131-therapy of benign thyroid disease.

Hänscheid H, Lassmann M, Reiners C. Hänscheid H, et al. Among authors: lassmann m. Z Med Phys. 2011 Dec;21(4):250-7. doi: 10.1016/j.zemedi.2011.01.006. Epub 2011 Apr 30. Z Med Phys. 2011. PMID: 21531122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters